Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Ketamine on Acute Pain in Females and Males
This study has been completed.
Study NCT00232492 Information provided by Ullevaal University Hospital
First Received: September 30, 2005 Last Updated: June 15, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mouth and Tooth Diseases
Tooth, Impacted
Additional conditions recognized in this trial
Stomatognathic Diseases
Tooth Diseases
Interventions listed in this trial
Placebo males
Ketamine 0,1 mg/kg males
Ketamine 0,3 mg/kg males
Ketamine 0,5 mg/kg males
Placebo females
Ketamine 0,1 mg/kg females
Ketamine 0,3 mg/kg females
Ketamine 0,5 mg/kg females
Additional drug interventions recognized in this trial
Ketamine
More general drug interventions related to this trial
Analgesics
Anesthetics
Anesthetics, Dissociative
Anesthetics, General
Anesthetics, Intravenous
Central Nervous System Agents
Central Nervous System Depressants
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Ullevaal University Hospital
Section of dental Pharmacology and Pharmacotherapy, University of Oslo, Norway
Back to top of Main Content
